Stocks
Allogene Therapeutics (ALLO) Net debt US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net debt, bln rub | -537.5 | -978.3 | -739.6 | -481.3 | -353.6 | -206.4 | |||
| Changes by years, y/y, % | -22% | +82% | -24% | -35% | -27% | -12.4% | |||
Allogene Therapeutics. Net debt, bln rub
Allogene Therapeutics. Net debt, changes, %
Allogene Therapeutics (ALLO) Net debt US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net debt, bln rub | -375.4 | -353.6 | -289.0 | -350.4 | -206.4 | -206.4 | ||
| Changes by years, y/y, % | -18% | -27% | -30% | -12% | -45% | |||
| Changes by quarters, q/q, % | -6% | -6% | -18% | +21% | -41% | |||
